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S tabilization of the systemic oxygen supply is the main goal of emergency and intensive care [1].  
Meeting tissue demands by balancing oxygen delivery 
and consumption is crucial for the management of crit-
ically ill patients [2].  However,  simultaneous hyperoxia 
is detrimental [3].  In 2010,  Kilgannon et al. [4] reported 
that arterial hyperoxia is independently associated with 
increased in-hospital mortality among patients admit-
ted to the intensive care unit following resuscitation 
from cardiac arrest.  Redox collapse is considered to be 
one of the major reasons.  Therefore,  knowledge and 
techniques that provide sufficient management of the 
redox regulation are necessary for intensive care spe-
cialists (Fig. 1) [5 , 6].
For the management of redox regulation in an inten-
sive care setting,  reducing the increase in oxidative 
stress is as important as controlling the oxygen supply.  
Within the filed of acute medicine,  research focused on 
redox regulation is newer than that concentrated on 
chronic diseases such as diabetes mellitus,  although 
many studies focused on oxidative stress in emergency 
settings have been reported [7].  Indeed,  oxidative 
stress is now one of the major targets of intensive care 
medicine [8].  Among the various treatments available 
for oxidative stress,  therapeutic hypothermia has been 
utilized to promote anti-oxidative neuroprotection in 
the daily management of multiple diseases [9].  In con-
junction with adequate intensive care management,  
therapeutic hypothermia is achieved by a single method 
or a combination of the following methods (Fig. 2) 
[10]: 1),  wrapping a patient with a blanket (or pad) in 
which cold liquid (or air) circulates [11]; 2),  inserting 
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a special endovascular cooling catheter intravenously 
[12]; 3),  administering cold Ringer’s solution; and 4) 
introducing an extracorporeal circulation system.  
Overall,  the target temperature is typically set to 
33-34°C (i.e.,  mild hypothermia),  which is maintained 
for 24-48 h,  and rewarming is introduced at a steady 
pace.  Mild therapeutic hypothermia has been shown to 
improve neurological outcome in post-cardiac arrest 
syndrome (PCAS) [13-15] and in neonatal hypoxic 
encephalopathy (neonatal asphyxia) [16-19].  In addi-
tion to these two disorders,  mild therapeutic hypother-
mia may be a promising therapy to treat traumatic brain 
injury (TBI) [20 , 21] and acute encephalopathy [22].
However,  there is still no global consensus on the 
effectiveness of therapeutic hypothermia.  In this report,  
we will provide an overview of the efficacy of therapeu-
tic hypothermia for neuroprotection from the perspec-
tive of redox regulation,  based on the findings from 
PCAS and TBI studies.
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Fig. 2　 Cooling techniques.  Various techniques are now available to induce and maintain therapeutic hypothermia.  Non-invasive exter-
nal cooling devices have recently made remarkable progress and have been shown to provide a suﬃcient cooling eﬀect comparable to that 
of invasive catheter techniques.  However,  neither technique reliably provides suﬃcient induction and/or maintenance of therapeutic hypo-
thermia when used alone,  and thus these methods must often be supplemented with other approaches.  ECMO: extracorporeal membrane 
oxygenation.
Fig. 1　 Dual nature of oxygen.  Oxygen has a two-sided charac-
ter,  both beneﬁting and harming humans and other mammals.  The 
implementation of precisely controlled and balanced oxygenation 
might be beneﬁcial for avoiding the damage from inadequate oxy-
genation,  which is mainly due to the production of reactive oxygen 
species.  In other words,  too much oxygen (hyperoxemia) may be 
just as harmful as insuﬃcient oxygen (hypoxemia),  because of the 
increased production of reactive oxygen species (oxygen toxicity) 
under both conditions.  ATP: adenosine triphosphate.
Pathophysiology of PCAS and TBI 
- Oxidative Stress and Lipid Peroxidation
To determine how oxidative stress affects the patho-
physiology of PCAS and TBI,  we reviewed the induc-
tion of oxidative stress and the mechanisms by which it 
injures the brain (Fig. 3).  Ischemia and reperfusion of 
tissue have been conclusively implicated in PCAS and 
TBI pathology [23, 24],  which often follow cardiac 
arrest or brain damage induced by a direct impact 
injury.  During ischemia,  the interrupted or decreased 
oxygen supply is typically balanced by a decrease in 
metabolism.  However,  during chronic ischemia,  the 
production of adenosine triphosphate decreases,  
because the demand for more oxygen exceeds the sup-
ply.  This event results in the influx of calcium ions fol-
lowed by the opening of voltage-dependent Ca2+ chan-
nels induced by malfunctioning Na+/K+-ATPase and the 
subsequent depolarization of the cell membrane.  
Calcium influx induces the production of reactive oxy-
gen species (ROS),  which is followed by the up-regula-
tion of nitric oxide synthase [25],  as well as activation 
of the xanthine oxidase system,  the arachidonate cas-
cade,  and the mitochondrial electron transport system 
[26].
Superoxide anion (•O2-) is generated after reperfu-
sion resumes the oxygen supply.  Superoxide dismutase 
(SOD) immediately converts superoxide anion to 
hydrogen peroxide,  which is subsequently converted 
(by the Fenton reaction in the presence of iron) to the 
strong oxidant hydroxyl radical (•OH).  The brain con-
tains the large amount of iron,  and thus provides a 
favorable condition for the generation of hydroxyl radi-
cals [27].  Superoxide anion forms peroxynitrite 
(OONO-) in the presence of nitric oxide (NO) (pro-
duced from activated NOS).  Peroxynitrite combines 
with carbon dioxide to produce nitrosoperoxocarbon-
ate (ONOOCO2),  which induces •NO2 and •CO3 [28].
These three by-products (i.e.  •OH/•NO2/•CO3) are 
cell-damaging free radicals with very high reactivity;  
they target the brain in particular,  because it is a rich 
source of polyunsaturated fatty acids.  The interaction 
with the phospholipid bilayer of the cell membrane 
triggers peroxidation of lipid,  which is relatively stable 
and hydrophobic,  and thus easily diffused into the 
cytoplasm.  This results in irreversible damage for the 
cell membrane or neuronal proteins.
Oxidative Stress in PCAS and TBI
Findings from animal experiments. Numerous 
laboratory studies have revealed that oxidant/antioxi-
dant effects play a major role in the pathophysiology of 
PCAS and TBI.  In the brains of cats exposed to a 
7.5-minute cardiac arrest,  thiobarbituric acid-reacting 
substances (TBARS) and conjugated dienes were 
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cell-damaging
free radicals
Fig. 3　 The oxidative stress cascade in diseases with ischemia/
reperfusion.  The up-regulation of NOS and the formation of super-
oxide anion result in increased production of ROS and RNS,  which 
further leads to oxidative stress and enhanced lipid peroxidation.  
These oxidative molecules further promote oxidative stress through 
a positive feedback loop,  resulting in exacerbation of neuronal dam-
age.  H2O2,  hydrogen peroxide; HOONO,  peroxynitrous acid; L•,  
lipid radical; LO•,  lipid alkoxyl radical; LOO•,  lipid peroxy radi-
cal; LH,  polyunsaturated fatty acid; LOOH,  lipid hydroperoxide;  
NOS,  nitric oxide synthase; O2•－,  superoxide; •OH,  hydroxyl radi-
cal; OONO－,  peroxynitrite; ONOOCO2,  nitrosoperoxocarbonate;  
RNS,  reactive nitrogen species; ROS,  reactive oxygen species;  
SOD,  superoxide dismutase.
increased by 339% and 286%,  respectively,  compared 
with the levels before cardiac arrest [29].  Exposure of 
human umbilical vein endothelial cells to plasma from 
out-of-hospital cardiac arrest (OHCA) patients increases 
the production of ROS and decreases anti-oxidants such 
as SOD,  glutathione,  and glutathione peroxidase [30].  
This indicates that plasma from OHCA patients induces 
acute endothelial cell toxicity leading to cell death.  In 
the cat TBI model (induced by fluid percussion),  •O2- 
in the cerebrospinal fluid is significantly increased com-
pared with the control [31].  An increase in 8-hydroxy- 
2’-deoxyguanosine (8-OHdG) in the nuclear and mito-
chondrial regions has been shown to occur early after 
cortical impact injury in rats [32].  Moreover,  oxidative 
injury of the blood-brain barrier (BBB) by shock wave 
pressure results in vascular edema,  BBB leakage,  and 
neurovascular inflammation and degeneration [33].
Findings from clinical studies. Several clinical 
studies have also shown an involvement of oxidative 
stress in PCAS and TBI.  One of these studies revealed 
the importance of oxidative stress in patients with car-
diac arrest using the oxidative stress index,  which is a 
ratio of the total oxidative status to the total antioxida-
tive status.  This study demonstrated that the oxidative 
stress index was increased in patients with PCAS and 
TBI,  and was found to be an independent predictor of 
early mortality after cardiopulmonary resuscitation 
[34].  In addition,  reductions of ascorbic acid and glu-
tathione in patients with TBI have been shown to 
involve a decrease of antioxidative status [35].  Presently,  
peroxiredoxin VI is a high-profile anti-oxidant marker,  
as its enzymatic activity is greatly decreased in the cere-
brospinal fluid of TBI patients.  Recovery of peroxire-
doxin VI activity 24 h after patient admission is a favor-
able prognostic factor,  whereas a continuous decrease in 
activity is a sign of poor prognosis [36].
Hypothermia and Oxidative Stress
Hypothermia causes various adverse effects related 
to temperature,  including electrolyte abnormality,  glu-
cose intolerance,  arrhythmia,  coagulopathy,  and 
immune suppression [37].  Moreover,  the rewarming 
process increases the oxygen demand as a result of met-
abolic enhancement,  and thus rapid rewarming may 
result in circulatory failure,  leading to an exacerbated 
outcome.  Therefore,  the ability to transport oxygen 
decreases during hypothermia and its rewarming pro-
cess,  thereby producing ROS and reactive nitrogen 
species (RNS),  hence oxidative stress [38].  Animal 
experiments have shown the effects of hypothermia on 
oxidant/antioxidant levels.  Alva et al.  [38] have demon-
strated the effects in rats that were cooled at a mean rate 
of 0.25°C per minute to reach 22°C and then rewarmed 
1 h after hypothermia at a rate of 0.35°C per minute to 
37°C.  These interventions elevated nitrites/nitrates and 
lipid peroxidation and decreased antioxidants,  such as 
SOD and catalase,  in the plasma [38].  Despite these 
effects,  hypothermia has been shown to confer a neuro-
protective effect,  and thus it was recently recom-
mended as a treatment for PCAS and neonatal hypoxic 
encephalopathy.
Therapeutic Hypothermia and Oxidative  
Stress in Ischemia/Reperfusion
Multiple studies have demonstrated the positive 
effects of hypothermia against oxidative stress in animal 
ischemia/reperfusion models (Table 1) [39-43].  Recently,  
Ostadal et al.  [44] reported interesting in vivo data that 
could be applied under clinical settings.  In their study,  
mild therapeutic hypothermia (33°C) was found to be 
superior to normothermia (36.8°C) against oxidative 
stress in porcine cardiac arrest.  After 20 min of cardiac 
arrest,  the circulation was restored by extracorporeal 
membrane oxygenation.  Moreover,  the reactive oxygen 
metabolite (ROM) levels were significantly lower in the 
hypothermia group than the normothermia group [44].  
In a clinical study evaluating ROM production (deriva-
tives of ROM; d-ROM) and the antioxidant capacity in 
the plasma of PCAS patients,  the level of d-ROMs 
during hypothermia (33°C) was significantly sup-
pressed compared with pre-hypothermia levels.  This 
level increased with rewarming and was correlated with 
brain temperature [45].
Further studies will be needed to determine why the 
effects of hypothermia differ according to the presence 
or absence of ischemia/reperfusion.  One possible 
mechanism for these differential effects may be the 
presence of GluR2 (the α-amino-3-hydroxy-5-meth-
yl-4-isoxazolepropionic acid receptor subunit).  GluR2 
in hippocampal CA1 neurons inhibits calcium influx,  
and during ischemia,  this subunit is downregulated.  
However,  hypothermia (32°C) 1 h after forebrain isch-
emia attenuates this down-regulation,  resulting in the 
inhibition of calcium influx,  hence excitotoxicity [46].  
In addition,  microarray analysis in a rat model of TBI 
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has shown that hypothermia (33°C) alters miRNA 
expressions,  which may subsequently affect redox reg-
ulation [47].  Therefore,  differences in GluR2 levels 
could be responsible for the discrepancy in the hypo-
thermia protocol,  in addition to the target temperature,  
speed of cooling or rewarming,  or duration of hypo-
thermia,  all of which varied among the studies (Fig. 4).
Future Outlook
The mechanism underlying therapeutic hypother-
mia is not just restricted to redox regulation.  Numerous 
studies have demonstrated that this therapy is neuro-
protective in multifactorial ways (Table 2) [10].  However,  
some clinical studies with large population sizes 
revealed that mild hypothermia management (com-
pared with a targeted temperature management of 36°C) 
did not contribute to better outcome for patients with 
traumatic brain injury or post-cardiac arrest syndrome 
[48 , 49].  The discrepancy developed between experi-
mental/animal data and human clinical trials of the 
effects of hypothermia management [50].  The question 
at this point is,  for whom is mild hypothermia manage-
ment beneficial? Unfortunately,  there is no clear answer.  
The heterogeneous nature of human injury plays a large 
role in this knowledge gap.  The evaluation of redox 
environment in a clinical setting may enhance our 
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Table 1　 Eﬀects of therapeutic hypothermia on redox regulation in animal models of ischemia/reperfusion
Authors Model TT (℉C) Therapeutic eﬀects of hypothermia
Brooks et al.,  2002 ﹇40﹈ MCAO in pigs 33-35 Preserved NAA and GSH in the brain
Karabiyikoglu et al.,  2003 ﹇41﹈ MCAO in rats 33 　 Decreased iNOS expression and preserved nitrotyro-sine-positive cells in the brain
Stefanutti et al.,  2005 ﹇42﹈ I/R in rats 30-32 Decreased MDA and NOx in the plasma Decreased MDA and preserved GSH/GSSG ratio in the ileum
Grezzana Filho et al.,  2011 ﹇43﹈ I/R in rats 26 　 Decreased TBARS and catalase in the liver
Alva et al.,  2013 ﹇44﹈ Hypoxia (10% O2) in rats 22 　
Decreased TBARS and NOx in the plasma Decreased 
TBARS and preserved GSH/GSSG ratio in the liver
GSH,  glutathione; GSSG,  glutathione disulﬁde; iNOS,  inducible nitric oxide synthase; I/R,  ischemia/reperfusion; MCAO,  middle cere-
bral artery occlusion; MDA,  malondialhehyde; NAA,  N-acetylasparate; NOx,  nitric oxide (nitrate plus nitrite); TBARS,  thiobarbituric acid 
reactive substances; TT,  target temperature.
Table 2　 Mechanisms of neuroprotective action of hypothermia
Decreased cerebral metabolism of glucose and oxygen consump-
tion
Reduced apoptosis and mitochondrial dysfunction
Prolonged cerebral excitatory cascade
Decreased the inﬂammatory response
Reduced vascular and membrane permeability
Reduced oxygen radical production
Altered expression of “cold shock proteins”
Minimized risk of thrombosis
Reduced risk of epileptic activities through electrical stabilizing 
properties
Fig. 4　 Therapeutic hypothermia and redox regulation.  The oxi-
dant‒anti-oxidant status is normally balanced,  but injury can induce 
an oxidative environment.  While hypothermia itself also promotes 
an oxidative environment,  therapeutic hypothermia for ischemic/
reperfusion damage can suppress oxidative stress and augment 
anti-oxidative action.  The reasons for the discrepant eﬀects of 
hypothermia between the presence or absence of ischemia/reper-
fusion remains unknown.  However,  the oxidant-anti-oxidant bal-
ance may be inﬂuenced by surrounding factors,  including target 
temperature and speed of cooling and rewarming.
understanding of this heterogeneity.  Therefore,  we pro-
pose the following hypotheses to explain this heteroge-
neity and suggest future research that focuses on redox 
regulation.
Hypothesis 1: Hypothermia therapy is not effective 
due to a redox collapse too great to be recovered by 
clinical management. The indication of hypother-
mia therapy has mainly been discussed with clinical 
events that are mechanically unrelated to the formation 
of brain injury (e.g.,  out-of-hospital or in-hospital car-
diac arrest,  schockable or non-shockable rhythm) [50].  
Little is known about the indications for hypothermia 
management for TBI or PCAS based on direct factors 
that aggravate brain injury,  such as redox environment.  
Therefore,  we suggest a clinical research that evaluates 
the association between various points of a redox envi-
ronment in a clinical setting and the neurological out-
come of patients.  These measured values may be useful 
for identifying patients who would most benefit from 
mild hypothermia therapy.  Serum samples,  as well as 
cerebrospinal fluid (CSF),  which should directly reflect 
the neurological environment,  should be used to evalu-
ate the redox environment.
Recently,  several automatic analyzers for redox 
environments have become available [51 , 52].  We have 
published studies evaluating the redox status in humans 
and animals using a Free Radical Analytical System 4 
(Diacron International,  Grosseto,  Italy) and a Free 
Radical Elective Evaluator (Diacron International) [53-
55],  by which both oxidative stress (d-ROMs) and the 
anti-oxidative status (biological antioxidant poten-
tial; BAP) can be measured within a few minutes.  
These devices are compact.  A total serum or CSF sam-
ple of 20 μL is all that is required to detect both d-ROMs 
and BAP.  The d-ROMs/BAP ratio and BAP/d-ROMs 
ratio are now commonly used to evaluate the oxidative 
or anti-oxidative potential,  respectively [51 , 52 , 56].
Several antioxidants,  such as progesterone and 
N-acetyl cysteine,  have been demonstrated in clinical 
trials to be effective antioxidant treatments for TBI 
patients [57-59].  Although some of these agents were 
tested in experimental PCAS animal models [60 , 61],  to 
date there has been no clinical study involving the use of 
these agents in PCAS patients.  It is possible that better 
clinical outcomes could be achieved with therapeutic 
hypothermia by identifying the optimal dosage and 
therapeutic window for treatment.
Hypothesis 2: Hypothermia therapy is not effective 
due to aggravated oxidative stress as a result of the 
clinical management procedure.
1. Muscle relaxants. Shivering is a defense mech-
anism for temperature regulation that comprises invol-
untary,  rapid,  and oscillating contractions of skeletal 
muscles [62],  and is one of the main concerns with the 
introduction of hypothermia management.  Additionally,  
shivering leads to increased oxygen consumption in 
response to increased metabolic demands [63].  
Although there has been no clinical study about the 
direct effect of shivering on redox regulation,  it is easily 
assumed that this vital response also affects the redox 
environment.  Therefore,  muscle relaxants could pre-
vent this adverse response,  and may contribute to better 
redox management.  Conversely,  the use of muscle 
relaxants has disadvantages in critical care management 
because of muscle weakness [64] and the association 
with mechanical ventilation and intensive care over lon-
ger periods of use [65].  Thus,  the use of this medica-
tion is a critical evaluation point in therapeutic hypo-
thermia.
2. Sedative agents. Some sedative agents,  such as 
propofol and melatonin,  have been reported to contrib-
ute to redox regulation and better outcome [66 , 67].  
The choice of these agents may have an additional effect 
in hypothermia management.
3. Methods for inducing hypothermia. Multiple 
clinical reports have cited the effectiveness and safety of 
both invasive and non-invasive cooling systems [68-70].  
There have also been reports investigating the therapeu-
tic window and speed of cooling.  Although experi-
mental animal studies have shown that early and fast 
cooling is essential for PCAS [71-73],  clinical trials have 
yielded conflicting results on the benefit of fast cooling 
[74-79]; thus there are no established recommenda-
tions with respect to the materials and methods for ini-
tiating hypothermia introduction.  It would be worth-
while to investigate differences in the association 
between the redox regulation and clinical outcomes 
under different methods of hypothermia induction.
4. Rewarming. While rapid rewarming has been 
reported to be associated with worse outcome [80 , 81],  
one study also showed that prolonged rewarming dura-
tion of 28 h or longer might increase complications in 
PCAS [82].  Further studies are needed to determine the 
relationship between the redox environment and clini-
cal outcome in the rewarming process in order to opti-
mize the rewarming duration.
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Conclusion
Further studies will be needed before reaching any 
definitive conclusions regarding the clinical effective-
ness of therapeutic hypothermia for TBI and PCAS.  
Redox status may be a key factor to bridge the knowl-
edge gap between experimental and clinical studies on 
hypothermia management.
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